Insight

Chiara Corti: Our ASCO Daily News editorial “IMpassion132”

Chiara Corti/LinkedIn

Aug 19, 2024, 06:51

Chiara Corti: Our ASCO Daily News editorial “IMpassion132”

Chiara Corti shared a post on LinkedIn:

“Check out our American Society of Clinical Oncology (ASCO) Daily News editorial ‘IMpassion132: Learning From Immunotherapy’s Failures in Early Relapsing Triple-Negative Breast Cancer’. ”

Source: Chiara Corti/LinkedIn

More posts by Chiara Corti in OncoDaily.

Chiara Corti is currently a Clinical Research Fellow at Dana-Farber Cancer Institute in Boston, focusing on early drug development for patients with solid tumors, with a special commitment to breast cancer. Since November 2019, she has also been a Medical Oncology Fellow at the European Institute of Oncology (IEO).

American Society of Clinical Oncology ASCO ASCO Daily News cancer Chiara Corti Dana-Farber Cancer Institute immunotherapy IMpassion132 OncoDaily Oncology triple-negative breast cancer

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer